openPR Logo
Press release

Biopharmaceutical Contract Manufacturing 2018 Global Industry Size,Analysis,Opportunities,Forecasts to 2023

01-11-2018 03:40 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: WiseGuy Research Consultants Pvt. Ltd.

/ PR Agency: WiseGuy Research Consultants Pvt. Ltd.
Biopharmaceutical Contract Manufacturing Market 2018

Biopharmaceutical Contract Manufacturing Market 2018

WiseGuyReports.Com adds “Biopharmaceutical Contract Manufacturing 2018 Global Industry Size,Analysis,Opportunities,Forecasts to 2023” Research to its Database.

Description:

Biopharmaceutical Contract Manufacturing Market

Biopharmaceuticals are also known as biologics. Biopharmaceutical products are pharmaceutical drugs that are synthesized, processed, or extracted from biological sources. Biopharmaceuticals include vaccines, blood products, recombinant therapeutic proteins, allergens, gene therapies, tissues and living cells used in cell therapy. Many companies outsource the manufacturing of biopharmaceuticals due to lack of manufacturing capabilities or in order to reduce the cost of manufacture process.Contract manufacturing organizations offer a wide range of services such as cell line development, process optimization, fermentation biotechnology, analytical characterization, cGMP manufacturing, and validation in each stage of clinical development and commercialization.

Biopharmaceutical contract manufacturing market is mainly driven by increase in investment of the pharma and biotechnological companies to develop and commercialize the biotechnological products. In addition, high revenue generation of blockbuster biological drugs such as humira, rituxan, lantus, avastin, herceptin and remicade are gaining traction from many biologics manufacturers. Advancements in the biotechnology such as recombinant DNA technologies and targeted drug therapies are expected to bolster the biopharmaceutical contract manufacturing market over the forecast period. Furthermore, to meet demand for biological products, companies are outsourcing the biopharmaceutical manufacturing to various contract manufacturing companies. However, high cost associated with manufacture and stringent regulatory requirements are expected to hamper the growth of biopharmaceutical contract manufacturing market.

Get a Sample Report @ https://www.wiseguyreports.com/sample-request/2753910-global-biopharmaceutical-contract-manufacturing-market-2012-to-2023

For more information or any query mail at sales@wiseguyreports.com

Biopharmaceutical contract manufacturing market segmented based on manufacturing process, type of services, molecule type and end user

Based on manufacturing process, biopharmaceutical contract manufacturing market is segmented into
Mammalian Based
Microbial Based
Insect Based
Plant Based
Yeast Based
Others

Based on type of service, biopharmaceutical contract manufacturing market is segmented into
Formulation
Fill and Finish services
Cell Banking
Analytical Services
Process development
Others

Based on molecule type, biopharmaceutical contract manufacturing market is segmented into
Large Molecules
Small Molecules

Based on end-user, biopharmaceutical contract manufacturing market is segmented into
Biopharmaceutical Companies
Pharmaceutical Companies
Research Organizations
Others

Global biopharmaceutical contract manufacturing market is expected to grow at a significant rate during the forecast period. The market is highly competitive where the speed to market is imperative along with efficient process and low costs. Biopharmaceutical contract manufacturing services providers are increasing their service offerings such as formulation, production and analytical services apart from conventional services to provide complete support for biopharmaceutical companies. Cost considerations and quick services are expected continue to drive the outsourcing of biopharmaceutical contract manufacturing market. In May 2017, Lonza Group Ltd. acquired cell and gene contract manufacturer PharmaCell B.V., this acquisition broadens Lonza’s capabilities in Europe region. Companies expanding the manufacturing facilities to increase market share. For instance, In May 2017, Boehringer Ingelheim GmbH started a new manufacturing facility in China to increase their manufacturing capacity. Through this facility company’s manufacturing capacity will increase by one-third.

Geographically biopharmaceutical contract manufacturing market has been segmented into following regions viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America and Europe are expected to be leading in biopharmaceutical contract manufacturing owing to increased approvals of biosimilars and increase in biopharmaceutical research organization which are lack of manufacturing facilities. In Asia-Pacific region, emerging countries such as China and India expected to grow at a rapid rate owing to low cost of manufacturing. Development of biologics pipeline by domestic companies expected to drive the growth of biopharmaceutical contract manufacturing in China.

Some of the players in biopharmaceutical contract manufacturing market are Lonza Group Ltd. (Switzerland), Boehringer Ingelheim GmbH (Germany), Charles River Laboratories, Inc. (U.S), Novartis AG (Switzerland) WuXi AppTec Group (China), Rentschler Biotechnologie GmbH (Germany), Fujifilm Holdings Corporation (Japan), Celonic AG (Switzerland), BIOMEVA GmbH (Germany), and ProBioGen AG (Germany) to name a few.

In June 2016, Moderna Therapeutics and Charles River Laboratories International, Inc., an early-stage contract research organization (CRO), are collaborated to support Moderna’s nonclinical discovery and development efforts.

Ask Query @ https://www.wiseguyreports.com/enquiry/2753910-global-biopharmaceutical-contract-manufacturing-market-2012-to-2023

Table Of Contents – Major Key Points

1. Executive Summary

2. Global Biopharmaceutical Contract Manufacturing Market Introduction
2.1. Global Biopharmaceutical Contract Manufacturing Market – Taxonomy
2.2. Global Biopharmaceutical Contract Manufacturing Market –Definitions
2.2.1. Manufacturing Process
2.2.2. Type of Service
2.2.3. Molecule Type
2.2.4. End-Use Type

3. Global Biopharmaceutical Contract Manufacturing Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Biopharmaceutical Contract Manufacturing Market Dynamic Factors - Impact Analysis
3.6. Global Biopharmaceutical Contract Manufacturing Market – Regulations
3.6.1. U.S.
3.6.2. Europe
3.7. Global Biopharmaceutical Contract Manufacturing Market –Trends

4. Global Biopharmaceutical Contract Manufacturing Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023
4.1. Market Analysis, 2012 – 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis

5. Global Biopharmaceutical Contract Manufacturing Market, By Manufacturing Process, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.1. Mammalian Based
5.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Microbial Based
5.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Insect Based
5.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Plant Based
5.4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Yeast Based
5.5.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
5.6. Others
5.6.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.6.3. Market Opportunity Analysis

6. Global Biopharmaceutical Contract Manufacturing Market Forecast, By Type of Service, 2012 - 2016 and Forecast, 2017 – 2023
6.1. Formulation
6.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Fill and Finish services
6.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Cell Banking
6.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Analytical Services
6.4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Process development
6.5.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
6.6. Others
6.6.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.6.3. Market Opportunity Analysis

7. Global Biopharmaceutical Contract Manufacturing Market Forecast, By Molecule Type, 2012 - 2016 and Forecast, 2017 – 2023
7.1. Large Molecules
7.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Small Molecules
7.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis

Continue…….

Buy 1-User PDF @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=2753910

For more information or any query mail at sales@wiseguyreports.com

ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.

Office No.528,Amanora Chambers,Magarpatta Road,Hadapsar,Pune-411028.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biopharmaceutical Contract Manufacturing 2018 Global Industry Size,Analysis,Opportunities,Forecasts to 2023 here

News-ID: 896591 • Views: 228

More Releases from WiseGuy Research Consultants Pvt. Ltd.

Surveillance 2018 Global Market Net Worth US$ 43600 million Forecast By 2022
WiseGuyReports.Com Publish a New Market Research Report On –“ Surveillance 2018 Global Market Net Worth US$ 43600 million Forecast By 2022”. Description: The Surveillance industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Surveillance market size to maintain the average annual growth rate of 11.54% from 17980 million $ in 2014 to 24950 million $ in 2017, The analysts believe that in the
Tunnel Boring Machine (TBM) Market 2018 Global Analysis By Key Players – Herre …
WiseGuyReports.Com Publish a New Market Research Report On –“ Tunnel Boring Machine (TBM) Market 2018 Global Analysis By Key Players – Herrenknecht, CRTG, CRCHI, Robbins, Tianhe, Komatsu, Mitsubishi”. Description: The Tunnel Boring Machine (TBM) industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Tunnel Boring Machine (TBM) market size to maintain the average annual growth rate of 7.11% from 1880 million $ in
Ultra Fine Copper Powder 2018 Global Market Net Worth US$ 405 million Forecast B …
WiseGuyReports.Com Publish a New Market Research Report On –“ Ultra Fine Copper Powder 2018 Global Market Net Worth US$ 405 million Forecast By 2022”. Description: The Ultra Fine Copper Powder industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Ultra Fine Copper Powder market size to maintain the average annual growth rate of 5.27% from 270 million $ in 2014 to 315 million
Car Leasing Market 2018 Global Share,Trend,Segmentation and Forecast to 2022
WiseGuyReports.Com Publish a New Market Research Report On –“ Car Leasing Market 2018 Global Share,Trend,Segmentation and Forecast to 2022”. Description: The Car Leasing industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Car Leasing market size to maintain the average annual growth rate of X% from XXXX million $ in 2013 to XXXX million $ in 2016, The analysts believe that in the

All 5 Releases


More Releases for Biopharmaceutical

Global Biopharmaceutical Stability Testing Market
According to a new market research report published by Global Market Estimates, the Global Biopharmaceutical Stability Testing Market is projected to grow from USD 3.2 billion in 2022 to USD 10.8 billion in 2027 at a CAGR of 13.3% from 2022 to 2027. Intertek Group plc, Eurofins Scientific, Pacific Biolabs, SGS SA, Element Materials Technology, Almac Group, Merck KGaA, Catalent, Inc., Pace Analytical Life Sciences, Boston Analytical, Kemwell Biopharma, Curia Global,
Biopharmaceutical Testing Services Market 2021 | Detailed Report
The top-notch information research report published by markets and markets is a vital asset that offers qualitative and quantitative factors of the Biopharmaceutical Testing Services market. The research study and methodologies mentioned in the report examine the critical vendors by considering their contribution to the global market. Furthermore, the report offers an in-depth insight into leading players’ performance based on revenue generation and client requirements. Also, the research report reveals
BioPharmaceutical Tubing Market 2021 | Detailed Report
According to Market Study Report, BioPharmaceutical Tubing Market provides a comprehensive analysis of the BioPharmaceutical Tubing Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team. Get Free Sample PDF (including full TOC, Tables and Figures) of BioPharmaceutical Tubing Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5024225 The report provides a comprehensive analysis of
Biopharmaceutical Market - Massive Growth opportunity Ahead
A new research document with title 'State of the Biopharmaceutical Industry 2021' covering detailed analysis, Competitive landscape, forecast and strategies. The study covers geographic analysis that includes regions and important players/vendors. The report will help user gain market insights, future trends and growth prospects for forecast period of 2021 Get customization & check discount for report @ https://www.htfmarketreport.com/request-discount/3060794-state-of-the-biopharmaceutical-industry Summary 2021 promises to be a year of continued innovation and change in the
Biopharmaceutical Logistics Market Is Thriving Worldwide |
The Biopharmaceutical Logistics Market Research Report aims to provide insights that strongly demonstrate the market structure, scope, history, potential, and development perspective. By crossing through the historical and present market status, the Biopharmaceutical Logistics market report provides authentic and reliable estimates for the forecast period. It became essential to distinguish the saturation of consumption in the Biopharmaceutical Logistics market owing to building competitiveness. Hence, the report furnishes a deep-felt market segmentation
The Future Of Investing: Biopharmaceutical Logistics Market
The pharmaceutical industry is dynamic and is likely to experience high growth in the coming years. Today, growing sales of drugs and biologics, changing dynamics of the pharmaceutical industry, and stringent regulatory controls are some of the factors boosting the demand for pharmaceutical logistics services.  Outsourcing logistics operations are trending in the pharma industry for cost optimization and technology advancement. Pharmaceutical companies are facing tremendous pressure for cutting down the cost of